Centre Hospitalier Universitaire de Nice

Futó vizsgálatok

• Még nem toboroz

  Safety and Efficacy of a STOPping Strategy Versus Classical Maintenance Dose of JAK Inhibitors in Deep Remission Patients With Ulcerative Colitis

  NCT07718529· 4. fázis· Assistance Publique Hopitaux De Marseille· Forrás

• Még nem toboroz

  Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis

  NCT07441408· 3. fázis· Bristol-Myers Squibb· Forrás

• Még nem toboroz

  Analysis of histological risk factors and biomarkers in paediatric retinoblastoma

  2024-515962-15-00· 2. fázis· Institut Curie· Forrás

• Még nem toboroz

  Prognostic and Predictive Factors in Childhood Soft Tissue Sarcomas

  NCT07924384· Institut Curie· Forrás

• Még nem toboroz

  FirST Lines of Biologics in pAtients With ulceRaTivE Colitis: a Randomised Controlled Trial

  NCT07576452· 4. fázis· University Hospital, Clermont-Ferrand· Forrás

• Még nem toboroz

  A Multicenter Study of Belantamab Mafodotin and Mezigdomide in Patients With Relapsed Multiple Myeloma

  NCT07612787· 1/2. fázis· Centre Hospitalier Universitaire de Saint Etienne· Forrás

• Még nem toboroz

  Efficacy of Upadacitinib Re-induction Therapy in Patients With Ulcerative Colitis Who Lost Response to 30 mg Maintenance Dose

  NCT07700446· 4. fázis· Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives· Forrás

• Toboroz

  Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease

  NCT07781644· 2. fázis· Hoffmann-La Roche· Forrás

• Még nem toboroz

  A study in young people and adults to learn about the medicine ritlecitinib for treatment of patchy hair loss, known by the medical term as moderate alopecia areata

  2026-526355-62-00· 3. fázis· Pfizer Inc.· Forrás

• Még nem toboroz

  A study to investigate safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis (stage F4 fibrosis) due to MASH (NEBULA-2)

  2026-525757-37-00· 3. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Még nem toboroz

  A pivotal clinical study to investigate the safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis due to Metabolic dysfunction-associated steatohepatitis (MASH)

  2026-525755-82-00· 3. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Még nem toboroz

  Phenotypic and Functional Characterization of Bone Marrow Macrophages in Chronic Myelomonocytic Leukemia

  NCT07852494· Centre Hospitalier Universitaire de Nice· Forrás

• Még nem toboroz

  Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled Trial

  NCT07818356· 4. fázis· University Hospital, Toulouse· Forrás

• Toboroz

  Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse

  NCT07871864· 3. fázis· Gustave Roussy, Cancer Campus, Grand Paris· Forrás

• Még nem toboroz

  Evaluate the superiority of Treatment with RAvulizumab vs plasma exchange during the first episode or a relapse In acute neuromyelitis optica (NMO) patients: a national, multicentric, randomised trial

  2026-526632-39-00· 3. fázis· Les Hopitaux Universitaires De Strasbourg· Forrás

• Még nem toboroz

  Evaluation of the Axomove Therapy Medical Device to Facilitate Adapted Physical Activity for Patients With Obesity

  NCT07903025· Axomove· Forrás

• Toboroz

  A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity

  NCT07843498· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  Comparison of Arterial and Capillary Blood Gas Analyses in Patients With Respiratory Distress Due to COPD or APE

  NCT07835945· Centre Hospitalier Universitaire de Nice· Forrás

• Toboroz

  Methotrexate Treatment in Hand Osteoarthritis Refractory to Usual Treatments

  NCT07501507· 2/3. fázis· Centre Hospitalier Universitaire de Nice· Forrás

• Toboroz

  Evaluating Aganirsen Eye Drops to Reduce the Number of Aflibercept Injections in Wet Age-Related Macular Degeneration Patients.

  2026-526775-27-00· 2. fázis· Laboratoires Kol· Forrás

• Toboroz

  A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

  NCT07465289· 3. fázis· UCB Biopharma SRL· Forrás

• Még nem toboroz

  A Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies

  NCT07719348· 1/2. fázis· Servier· Forrás

• Toboroz

  Feasibility of the Application of a new Six-month Treatment for multidrug-resistant tuberculosis (MDR-TB) patients in France (FAST-MDR)

  2024-512763-32-00· 3. fázis· Assistance Publique Hopitaux De Paris· Forrás

• Toboroz

  A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

  NCT07623161· 3. fázis· Takeda· Forrás

• Toboroz

  A Phase IIb Study to Evaluate AZD8965 in Participants with Idiopathic Pulmonary Fibrosis (IPF)

  2025-525016-41-00· 2. fázis· AstraZeneca AB· Forrás

• Még nem toboroz

  Obinutuzumab for Systemic Lupus Erythematosus Pure Membranous Nephropathy: a Phase II Trial

  NCT07721363· 2. fázis· Assistance Publique - Hôpitaux de Paris· Forrás

• Még nem toboroz

  Topical Clobetasol Propionate for Inflammatory Hand Osteoarthritis

  NCT07812701· 2. fázis· Assistance Publique - Hôpitaux de Paris· Forrás

• Még nem toboroz

  Impact of discontinuation of long-term macrolides in stable Non Cystic Fibrosis Bronchiectasis : a multicenter randomized controlled trial

  2025-521493-33-00· 3. fázis· Centre Hospitalier Intercommunal Creteil· Forrás

• Még nem toboroz

  OBINUSS - A trial to evaluate a new drug in systemic sclerosis: obinutuzumab.

  2025-524003-68-00· 2. fázis· Assistance Publique Hopitaux De Paris· Forrás

• Toboroz

  International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)

  NCT07476729· 3. fázis· Charite University, Berlin, Germany· Forrás

• Még nem toboroz

  Mitochondrial Network Modulation Approach Using Hyperbaric Oxygen (HBO) Therapy and Nb-UVB for Treating Vitiligo

  NCT07557693· 2/3. fázis· Centre Hospitalier Universitaire de Nice· Forrás

• Még nem toboroz

  Prospective evaluation of response to treatment by analysis of measurable residual disease in younger adult patients (18-60 years) with acute myeloid leukemia (AML). The Backbone InterGroup (BIG)-2 umbrella trial from the Acute Leukemia French Intergroup (ALFA, FILO) - BIG2

  2026-525759-96-00· 4. fázis· Centre Hospitalier Universitaire De Toulouse· Forrás

• Toboroz

  Fight Osteosarcoma Through European Research evolving study platform from diagnosis to relapse (FOSTER evolving study platform)

  2023-505575-69-01· 3. fázis· Institut Gustave Roussy· Forrás

• Toboroz

  PRODIGE 104 – NEOPREDICT A multicenter phase II trial using transcriptomic signatures to personalize neoadjuvant chemotherapy for patients with resectable borderline pancreatic adenocarcinoma.

  2024-519753-11-00· 2. fázis· Fondation Franc.Cancerologie Digestive· Forrás

• Még nem toboroz

  Link Between ASCorbemia Level and Osteoporosis

  NCT07660484· Centre Hospitalier Universitaire de Nice· Forrás

• Toboroz

  A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)

  NCT07581002· 2/3. fázis· AbbVie· Forrás

• Toboroz

  A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)

  NCT07647510· 3. fázis· Dianthus Therapeutics· Forrás

• Toboroz

  Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

  NCT07284602· 3. fázis· PureTech· Forrás

• Toboroz

  Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma

  NCT07555938· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  Optimal Care With Guselkumab in Crohn's Disease / OPTIM Study A Prospective Open Label Interventional, Multicenter Study

  NCT07616687· 4. fázis· Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives· Forrás

• Toboroz

  A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis

  NCT07189325· 3. fázis· University Hospital, Montpellier· Forrás

• Toboroz

  Monitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised Myasthenia Gravis in Therapy With RYSTIGGO® (Rozanolixizumab)

  NCT07570589· Centre Hospitalier Universitaire de Nice· Forrás

• Meghívásos bevonás

  Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD

  NCT07652294· 2. fázis· Spyre Therapeutics, Inc.· Forrás

• Még nem toboroz

  A PRECISION MEDICINE RANDOMIZED TRIAL FOR PATIENTS WITH RELAPSED OR REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA BASED ON A FUNCTIONAL APPROACH. ALL-TARGET TRIAL

  2024-516570-30-00· 2. fázis· Centre Hospitalier De Versailles· Forrás

• Még nem toboroz

  ACTIVATE - Phase 1 Clinical Trial evaluating the combination of Actinomycin D and venetoclax in patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

  2025-524728-22-01· 1/2. fázis· Assistance Publique Hopitaux De Paris· Forrás

• Még nem toboroz

  Tdose Binding and Tocilizumab

  NCT07582185· 4. fázis· Centre Hospitalier Universitaire de Nice· Forrás

• Toboroz

  A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)

  NCT07357727· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

  NCT07463521· 3. fázis· UCB Biopharma SRL· Forrás

• Toboroz

  INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)

  NCT07429266· 3. fázis· Ono Pharmaceutical Co., Ltd.· Forrás

• Toboroz

  A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT07577856· 3. fázis· Janssen Research & Development, LLC· Forrás

Showing 50 of 453.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Gyermekkori daganatok36 toboroz
• Akut mieloid leukémia (AML)21 toboroz
• Crohn-betegség16 toboroz
• Mielodiszplasztikus szindróma (MDS)15 toboroz
• Myasthenia gravis13 toboroz
• Sclerosis multiplex (SM)13 toboroz
• Akut limfoid leukémia (ALL)10 toboroz
• Colitis ulcerosa10 toboroz
• Mieloproliferatív neopláziák10 toboroz
• Tüdőrák10 toboroz
• Melanóma9 toboroz
• Mielóma multiplex9 toboroz
• Zsírmáj (MASLD/MASH)9 toboroz
• Parkinson-kór7 toboroz
• Alzheimer-kór6 toboroz
• Elhízás6 toboroz
• Krónikus mieloid leukémia (CML)6 toboroz
• 2-es típusú cukorbetegség5 toboroz
• ANCA-asszociált vasculitis5 toboroz
• HIV-fertőzés5 toboroz
• Idiopátiás tüdőfibrózis5 toboroz
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)5 toboroz
• Magas vérnyomás5 toboroz
• Osteoarthritis5 toboroz
• Pikkelysömör5 toboroz
• Rheumatoid arthritis5 toboroz
• Szarkóma5 toboroz
• Vitiligo5 toboroz
• Amiotrófiás laterálszklerózis (ALS)4 toboroz
• Bronchiectasis4 toboroz
• Cisztás fibrózis4 toboroz
• Időskori makuladegeneráció4 toboroz
• Krónikus obstruktív tüdőbetegség (COPD)4 toboroz
• Máj- és epeúti rák4 toboroz
• Stroke (szélütés)4 toboroz
• Csontritkulás3 toboroz
• Glioblasztóma3 toboroz
• Liver cirrhosis3 toboroz
• Pulmonális artériás hipertónia3 toboroz
• Szívelégtelenség3 toboroz
• Alopecia areata2 toboroz
• Aplastic anaemia2 toboroz
• Friedreich-ataxia2 toboroz
• Lupus (SLE)2 toboroz
• Migrén2 toboroz
• Myocarditis2 toboroz
• Neuroblasztóma2 toboroz
• Neuroendokrin daganatok2 toboroz
• Neuromyelitis optica (NMOSD)2 toboroz
• Skizofrénia2 toboroz
• Szisztémás szklerózis (szkleroderma)2 toboroz
• Vastagbélrák2 toboroz
• Vesedaganat2 toboroz
• Amiloidózis1 toboroz
• Aortic aneurysm1 toboroz
• Arthritis psoriatica1 toboroz
• Atópiás dermatitisz (ekcéma)1 toboroz
• Bipoláris zavar1 toboroz
• Diabéteszes retinopátia1 toboroz
• Follikuláris limfóma1 toboroz
• Frontotemporális demencia1 toboroz
• Gout1 toboroz
• Hasnyálmirigyrák1 toboroz
• Hearing loss1 toboroz
• Hepatitis B (krónikus)1 toboroz
• Hepatitis C1 toboroz
• Hidradenitis suppurativa1 toboroz
• Hodgkin-limfóma1 toboroz
• Krónikus limfoid leukémia (CLL)1 toboroz
• Krónikus vesebetegség1 toboroz
• Long COVID és ME/CFS1 toboroz
• Peripheral artery disease1 toboroz
• Petefészekrák1 toboroz
• Pitvarfibrilláció1 toboroz
• Pompe-betegség1 toboroz
• Primer biliáris cholangitis (PBC)1 toboroz
• Spondylitis ankylopoetica (Bechterew-kór)1 toboroz
• Tuberkulózis1 toboroz

Lezárt vizsgálatok

• Toboroz

  Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

  2025-524335-39-00· 3. fázis· Gilead Sciences Inc.· Forrás

• Leállították

  Presence of Anti-RACH Antibodies and Neurocognitive Disorder in Myasthenic or Alzheimers's Patients.

  NCT06523296· Centre Hospitalier Universitaire de Nice· Forrás

• Lezárult

  A study to investigate the long-term safety, tolerability and efficacy of balinatunfib in participants with Crohn’s disease or ulcerative colitis

  NCT07222189· 2. fázis· Sanofi-Aventis Recherche & Developpement· Forrás

• Lezárult

  Study of the Effectiveness and Safety of Acasunlimab Alone or With Pembrolizumab in treating Advanced Melanoma of the Skin That Has Returned After or did not respond to Cancer Immunotherapy (ABBIL1TY MELANOMA-07)

  NCT06984328· 2. fázis· Genmab A/S· Forrás

• Fut, nem toboroz

  A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma

  NCT07288203· 2. fázis· Iovance Biotherapeutics, Inc.· Forrás

• Lezárult

  A multicentre, randomised, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of BP1.4979 in adult patients with essential tremor

  2024-517987-46-00· 2. fázis· Bioprojet Pharma· Forrás

• Lezárult

  A study to investigate efficacy and safety of SAR441566 in patients with ulcerative colitis

  NCT06867094· 2. fázis· Sanofi-Aventis Recherche & Developpement· Forrás

• Lezárult

  A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis

  NCT07225829· 2. fázis· 4Moving Biotech· Forrás

• Lezárult

  A study to investigate efficacy and safety of SAR441566 in patients with Crohn's disease.

  NCT06637631· 2. fázis· Sanofi-Aventis Recherche & Developpement· Forrás

• Lezárult

  Impact of Individual Radiosensitivity on Late Toxicities of Radiosurgery in Essential Trigeminal Neuralgia

  NCT06863324· Centre Hospitalier Universitaire de Nice· Forrás

• Lezárult

  A study to evaluate S227928 as a Single Agent and in Combination with Venetoclax in Patients with R/R AML, MDS/AML, or CMML

  NCT06563804· 1/2. fázis· Institut De Recherches Internationales Servier IRIS· Forrás

• Fut, nem toboroz

  A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis

  NCT06744920· 3. fázis· Novartis Pharmaceuticals· Forrás

• Visszavonták

  Towards Optimal Screening and Management of Coronary Artery Disease in Diabetes: TOSCANA Study

  NCT05314140· French Cardiology Society· Forrás

• Lezárult

  Long-Term Extension Study (AtDvance) to Evaluate the Safety and Efficacy of GSK1070806 in Participants with Moderate to Severe Atopic Dermatitis.

  NCT06447506· 2. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Lezárult

  ALS Phase II Study of NX210c

  NCT06365216· 2. fázis· Axoltis Pharma· Forrás

• Toboroz

  Efficacy and safety study of frexalimab (SAR441344) in adults with relapsing forms of multiple sclerosis

  2023-504358-36-00· 3. fázis· Sanofi-Aventis Recherche & Developpement· Forrás

• Lezárult

  Oral Azacitidine Maintenance Post-CPX 351

  NCT06349239· Centre Hospitalier Universitaire de Nice· Forrás

• Lezárult

  Safety and Efficacy of NMD670 in Adult Patients With Type 1 and Type 2 Charcot-Marie-Tooth Disease

  NCT06482437· 2. fázis· NMD Pharma A/S· Forrás

• Fut, nem toboroz

  To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications

  NCT06553027· 3. fázis· Cerevance· Forrás

• Fut, nem toboroz

  RVU120 for Treatment of Anemia in Patients With Lower-risk Myelodysplastic Neoplasms

  NCT06243458· 2. fázis· GCP-Service International West GmbH· Forrás

• Lezárult

  A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

  NCT06335303· 2. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  Safety and Efficacy of NMD670 in Adult Patients with Type 1 and Type 2 Charcot-Marie-Tooth Disease

  2023-507892-23-00· 2. fázis· NMD Pharma A/S· Forrás

• Lezárult

  A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of Exacerbations

  NCT06529419· 2. fázis· AstraZeneca· Forrás

• Fut, nem toboroz

  A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.

  NCT06517758· 3. fázis· Novartis Pharmaceuticals· Forrás

• Lezárult

  A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of PLN-74809 (bexotegrast) for the treatment of idiopathic pulmonary fibrosis (BEACON-IPF)

  2023-506185-31-00· 2/3. fázis· Pliant Therapeutics Inc.· Forrás

• Fut, nem toboroz

  A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

  NCT06456580· 3. fázis· Vor Biopharma· Forrás

• Lezárult

  A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)

  NCT06465186· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Leállították

  A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata

  NCT06444451· 2. fázis· Sanofi· Forrás

• Lezárult

  Clinical Trial to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/Nesolicaftor in Adults With CF

  NCT06468527· 2. fázis· Kors van der Ent· Forrás

• Lezárult

  A Phase IIb, Multicentre, Randomised, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/Nesolicaftor in Subjects with Cystic Fibrosis Aged 18 Years or Older (CHOICES)

  2022-500410-26-01· 2. fázis· University Medical Center Utrecht· Forrás

• Lezárult

  A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants with Moderate to Severe Ulcerative Colitis

  2023-506655-19-00· 2. fázis· Genentech Inc.· Forrás

• Leállították

  A Study to Test Long-term Treatment With Spesolimab in People With a Skin Condition Disease Called Hidradenitis Suppurativa (HS) Who Took Part in a Previous Study With Spesolimab

  NCT06241573· 2/3. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  EFFICACY AND SAFETY OF GSK4527226 [AL101] IN PATIENTS WITH EARLY ALZHEIMER’S DISEASE

  NCT06079190· 2. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Fut, nem toboroz

  A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)

  NCT06346067· 3. fázis· Erasca, Inc.· Forrás

• Fut, nem toboroz

  A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis

  NCT06298552· 3. fázis· argenx· Forrás

• Visszavonták

  Meaningful Aspects of Health for Adults With Dementia, Their Care Partners and Healthcare Practitioners

  NCT06242574· Centre Hospitalier Universitaire de Nice· Forrás

• Lezárult

  A Phase 2b, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Dose Finding study to evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GSK1070806 SC injection in Adult Participants with Moderate to Severe Atopic Dermatitis

  NCT05999799· 2. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Lezárult

  A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments

  NCT06323928· 2. fázis· H. Lundbeck A/S· Forrás

• Lezárult

  Latent Tuberculosis Infection Screening Using QuantiFERON at Pre-Employment Assessment in Hospital Workers CHu Nice

  NCT07608601· Centre Hospitalier Universitaire de Nice· Forrás

• Fut, nem toboroz

  A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis

  NCT06257875· 2. fázis· AbbVie· Forrás

• Lezárult

  Plasma Dosage of Venetoclax in the Fup of AML Patients Treated With Aza + Ven

  NCT06030089· Centre Hospitalier Universitaire de Nice· Forrás

• Fut, nem toboroz

  A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)

  NCT06282159· 2. fázis· Dianthus Therapeutics· Forrás

• Leállították

  Evaluation of Ultrasound Biomicroscopy in the Local Staging of Cutaneous Melanoma

  NCT04702854· Centre Hospitalier Universitaire de Nice· Forrás

• Lezárult

  A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis

  NCT06280391· 2. fázis· Sanofi· Forrás

• Lezárult

  Personality and Quality of Life Amelioration After Continuous Subcutaneous Apomorphine Infusion in Parkinson's Disease

  NCT06080399· University Hospital, Toulouse· Forrás

• Lezárult

  Single-dose Study of BMS-986326 at Two Dose Levels in Participants with Atopic Dermatitis

  2022-502997-18-00· 1. fázis· Bristol-Myers Squibb Services Unlimited Company· Forrás

• Lezárult

  A 96-Week, Prospective, Multicenter, Randomised, Double-Blind, Placebo-Controlled, Phase 3 Study to Compare Efficacy and Safety of Masitinib Dose Titration to 4.5 mg/kg/day versus Placebo in the Treatment of Patients with Primary Progressive or Secondary Progressive Multiple Sclerosis Without Relapse

  2024-516672-16-00· 3. fázis· Ab Science· Forrás

• Lezárult

  A Multicenter, Open-Label Clinical Trial of RVU120 in Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia with or without NPM1 Mutation (RIVER-52)

  2023-505910-10-00· 2. fázis· Ryvu Therapeutics S.A.· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids

  NCT06224348· 3. fázis· Sanofi· Forrás

• Lezárult

  Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

  NCT05934526· 3. fázis· GB002, Inc.· Forrás

Showing 50 of 185.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Vitiligo23 munka · 16 vizsgálat
• Migrén18 munka · 7 vizsgálat
• Mielodiszplasztikus szindróma (MDS)13 munka · 34 vizsgálat
• Alopecia areata12 munka · 6 vizsgálat
• Myasthenia gravis10 munka · 23 vizsgálat
• Mieloproliferatív neopláziák6 munka · 19 vizsgálat
• Charcot-Marie-Tooth disease3 munka · 3 vizsgálat